CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study

Authors :: Joseph P. McGuirk
Constantine S. Tam
Nicolaus Kröger
Peter A. Riedell
Hemant S. Murthy
Phoebe Joy Ho
Joseph E. Maakaron
Edmund K. Waller
Farrukh T. Awan
Paul J. Shaughnessy
Armin Ghobadi
Michael R. Bishop
Ana Alfonso-Pierola
Michael Dickinson
Praveen Ramakrishnan Geethakumari
Ainsley Ross
William Stevens
Huansheng Xu
Anna Ma
Sarah Beaussant Cohen
Richard T. Maziarz
Carlos Bachier
Source :: Blood. 140:10303-10306
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools